Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 1;491(7422):129-33.
doi: 10.1038/nature11443. Epub 2012 Sep 30.

Vaccine-induced CD8+ T cells control AIDS virus replication

Philip A Mudd  1 , Mauricio A Martins, Adam J Ericsen, Damien C Tully, Karen A Power, Alex T Bean, Shari M Piaskowski, Lijie Duan, Aaron Seese, Adrianne D Gladden, Kim L Weisgrau, Jessica R Furlott, Young-il Kim, Marlon G Veloso de Santana, Eva Rakasz, Saverio Capuano 3rd, Nancy A Wilson, Myrna C Bonaldo, Ricardo Galler, David B Allison, Michael Piatak Jr, Ashley T Haase, Jeffrey D Lifson, Todd M Allen, David I Watkins
Affiliations

Vaccine-induced CD8+ T cells control AIDS virus replication

Philip A Mudd et al. Nature. .

Abstract

Developing a vaccine for human immunodeficiency virus (HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals control replication of the virus. Most of these elite controllers express the histocompatibility alleles HLA-B*57 or HLA-B*27 (ref. 3). These alleles remain by far the most robust associations with low concentrations of plasma virus, yet the mechanism of control in these individuals is not entirely clear. Here we vaccinate Indian rhesus macaques that express Mamu-B*08, an animal model for HLA-B*27-mediated elite control, with three Mamu-B*08-restricted CD8(+) T-cell epitopes, and demonstrate that these vaccinated animals control replication of the highly pathogenic clonal simian immunodeficiency virus (SIV) mac239 virus. High frequencies of CD8(+) T cells against these Vif and Nef epitopes in the blood, lymph nodes and colon were associated with viral control. Moreover, the frequency of the CD8(+) T-cell response against the Nef RL10 epitope (Nef amino acids 137-146) correlated significantly with reduced acute phase viraemia. Finally, two of the eight vaccinees lost control of viral replication in the chronic phase, concomitant with escape in all three targeted epitopes, further implicating these three CD8(+) T-cell responses in the control of viral replication. Our findings indicate that narrowly targeted vaccine-induced virus-specific CD8(+) T-cell responses can control replication of the AIDS virus.

PubMed Disclaimer

Conflict of interest statement

All other authors declare no competing financial interests.

Figures

Figure 1
Figure 1
Experimental design. A) Mamu-B*08+ macaques were vaccinated with an identical rYF17D/rAd5 regimen. Group 1 received two SIVmac239 constructs: Vif 3′ (amino acids 102–214; includes the Mamu-B*08-restricted Vif123–131RL9 and Vif172–179RL8 epitopes) and Nef (amino acids 45–210; includes the Mamu-B*08-restricted Nef137–146RL10 epitope). Group 2 received two SIVmac239 constructs: Gag (amino acids 178–258) and Vif 5′ (amino acids 1–110), which do not contain any known Mamu-B*08-restricted CD8+ T cell epitopes. Animals were challenged with SIVmac239 intrarectally 15 weeks after the rAd5 boost. B) Frequencies of tetramer+ CD8+ T-cells in PBMC at days 7 and 14 following the rAd5 boost. Lines represent mean frequency.
Figure 2
Figure 2
In vivo viral replication. A) Plasma VLs for Group 1 animals. The dashed line (103 vRNA copies/mL) represents the threshold that defines elite control in Indian rhesus macaques. B) Plasma VLs for Group 2 animals. C) Geometric mean plasma VLs for Groups 1, 2, and unvaccinated Mamu-B*08+ (n = 4) or Mamu-B*08− (n = 8) control macaques. D) Plasma VL comparisons between Groups 1 and 2. Lines represent geometric means. E) Viral replication measured using in situ hybridization, in lymph node biopsy specimens. The mean value and the standard error of the mean are shown.
Figure 3
Figure 3
CD8+ T-cell responses in vaccinated animals following SIVmac239 infection. Peptide/Mamu-B*08 tetramer staining in A) PBMC, B) lymph nodes, and C) colon biopsies. Error bars represent standard error of the mean. D) Correlations between the frequency of tetramer+ cells and VL at week 2 post infection. E) Granzyme B production by SIV-specific CD8+ T-cells in Group 1 and Group 2 vaccinees at days 7 and 17 post-infection. F) Perforin production by SIV-specific CD8+ T-cells in Group 1 and Group 2 vaccinees at day 17 post-infection. Assay results are shown as sport forming cells (SFC) per 106 PBMC.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity. 2007;27:406–416. - PubMed
    1. Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol. 2004;4:630–640. - PubMed
    1. Migueles SA, Connors M. Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. JAMA. 2010;304:194–201. - PubMed
    1. Fellay J, et al. A whole-genome association study of major determinants for host control of HIV-1. Science. 2007;317:944–947. - PMC - PubMed
    1. Pereyra F, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010;330:1551–1557. - PMC - PubMed

Publication types

MeSH terms